http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3649632-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a717ea5b2ac78ac329ab3a9659d834d2
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D219-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D219-06
filingDate 1970-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1972-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a66b7775a93b519bccd3fef69cc2a5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7327eb257d2d3821767b4ae7687f63fb
publicationDate 1972-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-3649632-A
titleOfInvention 3 4-dihydroacridin-2-(1h)-one derivatives
abstract THE DISCLOSURE IS DIRECTED TO NOVEL 3,4-DIHYDROACRIDIN2(1H)-ONE DERIVATIVES OBTAINED BY THE REACTION OF OAMINOCARBONYL DERIVATIVES WITH CYCLOHEXANE-1,4-DIONE IN THE PRESENCE OF A STRONG ACID. THE COMPOUNDS ARE USEFUL AS CENTRAL NERVOUS SYSTEM DEPRESSANTS IN THAT THEY PRODUCE A CALMING EFFECT IN THE HOST.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5045433-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6030967-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9807705-A1
priorityDate 1970-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69878324
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428188450
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12870
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID432514979
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12511
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421024265
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154391016
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419516180

Total number of triples: 24.